Assessing genetic predisposition to cancer for confident decision making
The Hereditary Cancer Solution (HCS) by SOPHiA GENETICS detects genetic susceptibility to breast and ovarian cancer, HNPCC and intestinal polyposis syndromes. Entrusted by hundreds of healthcare institutions, it has already helped diagnose over 40K patients worldwide.
The HCS is a molecular diagnostic application that bundles a capture-based target enrichment kit with the analytical power of SOPHiA™ AI and full access to the SOPHiA DDM® platform, an intuitive user interface facilitating variants visualization and interpretation.
Benefits of the solution
Detection of all types of genomic alterations (i.e SNVs, Indels and CNVs) in 26 relevant genes associated with hereditary cancers
Clinical grade analytical performance
Compatible with market-leading sequencing platforms without impact on performance. The gene panel can also be adapted according to experts' needs
The library preparation step can be fully automated, for high throughput needs, without impacting data quality